Research of Burden of Interstititial Lung Diseases in Turkey

Study Overview
=================
Brief Summary
-----------------
The aim of our study is to investigate the etiological distribution of ILD, epidemiological characteristics of ILD cases such as age, gender, geography, smoking, occupation, economic status, education, and comorbidities. Another aim is to make the cost calculation from the first to the diagnosis in the patients diagnosed. Obtaining the missing data related to the ILD of our country is one of our goals.

Official Title
-----------------
Research of Burden of Interstititial Lung Diseases in Turkey

Conditions
-----------------
Lung Diseases, Interstitial, Fibrosis Lung

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients who are not previously diagnosed with ILD will be included in the study. Exclusion Criteria: under 18 years old older 80 years old

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 80 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Etiological distribution | The aim of our study is to investigate the etiological distribution of ILD | 1 year | 
| Etiological distribution | Geographic distribution of ILD patients according to regions (will be presented as %) | 1 year | 
| Epidemiological characteristics of ILD cases | Age (years) | 1 year | 
| Epidemiological characteristics of ILD cases | Gender (male, female; (will be presented as %)) | 1 year | 
| Epidemiological characteristics of ILD cases | Smoking (yes, no; (will be presented as %) | 1 year | 
| Epidemiological characteristics of ILD cases | Distribution of ILD patients according to the occupation (will be presented as %) | 1 year | 
| Epidemiological characteristics of ILD cases | Economic status (monthly salary of patients according to ILD types and stages of ILD) | 1 year | 
| Epidemiological characteristics of ILD cases | Distiribution of ILD patienst according to comorbidities (will be presented as YES or NO and %) Comorbiditites are; Hypertension, Heart failure, Coronary Artery Disease, Arrhythmia, Heart Valve Disease, Asthma, COPD, Chronic Renal Disease, Diabetes Mellitus, Hyper / Hypothyroidism, HIV, Cirrhosis / Chronic Liver Disease, Lung malignancy, Extrapulmonary solid organ malignancy, Hematologic malignancy, SVO, Alzeimer, Epilepsy, Neuromuscular Ill, Organ Transplant Receiver, Reflux, Slyding hernia, Others | 1 year | 
| Total number | We planned enroll roughly 1000 patients to the study | 1 year | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Clinical findings | According to the etiology of ILD, clinical findings (Rod, Ral, Rash, Arthritis, Alopecia, Erythema nodosum, Peripheral lymphadenomegaly, Cyanosis, Edema, Raynaud's phenomenon, Other) will be presented as YES or NO and % | 1year | 
| Pulmonary functions | According to the etiology of ILD, pulmonary functions, will be assessed; FVC (ml) and (%pred) | 1year | 
| Pulmonary functions | According to the etiology of ILD, pulmonary functions, will be assessed; FEV 1 (ml) and (%pred) | 1year | 
| Pulmonary functions | According to the etiology of ILD, pulmonary functions, will be assessed; DLCO (mL.min.mmHg) and (%pred) | 1year | 
| Pulmonary functions | According to the etiology of ILD, pulmonary functions, will be assessed; DLCO/VA (mL.min.mmHg) and (%pred) 6dk YT (meters) Pulseoksimetre ile PaO2 (%) | 1year | 
| Pulmonary functions | According to the etiology of ILD, pulmonary functions, will be assessed; 6min Walk Test (meters) | 1year | 
| Pulmonary functions | According to the etiology of ILD, pulmonary functions, will be assessed; PaO2 with Pulse oximeter (%) | 1year | 
| Diagnostic methods | According to the etiology of ILD, diagnostic methods used in ILD cases will be presented Diagnoses methods are; Clinical and radiology, Bronchoscopic transbronchial lung biopsy, Bronchoalveolar lavage, Transthoracic needle biopsy with imaging, EBUS, VATS, Thoracotomy, Other (Methods are will be shown as YES or NO and %) | 1year | 
| Time | According to the etiology of ILD, the time spent for diagnosis will be presented Time will be presented as months. | 1year | 
| Treatment methods | Determining the treatment preferences of physicians according to the etiology of the cases will be presented; Treatment methods are; Non-treatment monitoring, Symptomatic treatment, Systemic corticosteroid, Cytostatic drugs, Antifibrosan drugs (eg Pirfenidone, Nintedanib), Immunological therapy, Referral to other centers, Preparing for transplantation, Home oxygen therapy, Reflux therapy, Other (Methods are will be shown as YES or NO and %) | 1year | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Interstitial Lung Diseases, Fibrotic Lung, Prevalence